| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |